Stay updated on Aducanumab in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.

Latest updates to the Aducanumab in Early Alzheimer's Clinical Trial page
- CheckyesterdayChange DetectedAdded front-end revision v3.5.0 and removed revision v3.4.3; no changes to study content or user-facing information.SummaryDifference0.0%

- Check8 days agoChange DetectedNew revision entry v3.4.3 has been added. The previous revision entry v3.4.2 has been removed.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice as well as Revision: v3.4.1.SummaryDifference0.2%

- Check44 days agoChange DetectedAdministrative updates were made to the study page: a government funding status notice was added, a new 2023 publication entry was added, a record revision labeled v3.4.1 was noted, and an earlier Erratum publication entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check51 days agoChange DetectedAdded Show glossary and updated revision metadata to Revision: v3.4.0; adjusted QC and FEAR Act labels (e.g., capitalization) replacing previous variants.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.0%

Stay in the know with updates to Aducanumab in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.